Literature DB >> 10592426

Plasma nitric oxide metabolites and lipid peroxide levels in preeclamptic pregnant women before and after delivery.

U Mutlu-Türkoglu1, G Aykaç-Toker, L Ibrahimoglu, E Ademoglu, M Uysal.   

Abstract

It has been suggested that oxidative stress may cause endothelial dysfunction and that endothelial dysfunction may lead to hypertension by reduced release of vasodilating agents such as nitric oxide (NO). In this study, we investigated the relationship between serum NO and lipid peroxides in preeclamptic and normal pregnant women before and after delivery. Plasma from women with preeclampsia had significantly lower nitrate/nitrite concentrations and significantly higher lipid peroxide levels than normal pregnant women before the delivery. Lipid peroxide levels were significantly elevated in preeclamptic placenta. After delivery in the preeclamptic group the plasma concentration of nitrate/nitrite was increased and plasma thiobarbituric acid reactive substance levels decreased, while these parameters remained unchanged in the normal pregnants women. These results indicate that high levels of lipid peroxides in the circulation may be the cause of lowered NO synthesis and hypertension observed in preeclamptic women. Copyright 1999 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10592426     DOI: 10.1159/000010192

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  11 in total

1.  Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-10-01

2.  Analysis of nitroso-proteomes in normotensive and severe preeclamptic human placentas.

Authors:  Hong-hai Zhang; Yu-ping Wang; Dong-bao Chen
Journal:  Biol Reprod       Date:  2011-01-12       Impact factor: 4.285

3.  Circulating and Vascular Bioactive Factors during Hypertension in Pregnancy.

Authors:  Alain F Tanbe; Raouf A Khalil
Journal:  Curr Bioact Compd       Date:  2010-03-01

Review 4.  Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.

Authors:  Dania A Shah; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2015-04-24       Impact factor: 5.858

5.  Serelaxin improves the pathophysiology of placental ischemia in the reduced uterine perfusion pressure rat model of preeclampsia.

Authors:  Jose A Santiago-Font; Lorena M Amaral; Jessica Faulkner; Tarek Ibrahim; Venkata Ramana Vaka; Mark W Cunningham; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-09-14       Impact factor: 3.619

Review 6.  Oxidative stress in the placenta.

Authors:  Leslie Myatt; Xiaolan Cui
Journal:  Histochem Cell Biol       Date:  2004-07-10       Impact factor: 4.304

7.  Clinic significance of markedly decreased α-klothoin women with preeclampsia.

Authors:  Cuifang Fan; Yueqiao Wang; Jingyi Wang; Di Lei; Yanmei Sun; Sicong Lei; Min Hu; Yatao Tian; Rui Li; Suqing Wang
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

Review 8.  Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy.

Authors:  Stephanie J Sheppard; Raouf A Khalil
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2010-03

Review 9.  Preeclampsia: long-term consequences for vascular health.

Authors:  Lorena M Amaral; Mark W Cunningham; Denise C Cornelius; Babbette LaMarca
Journal:  Vasc Health Risk Manag       Date:  2015-07-15

10.  Role of vitamins C and e in regulating antioxidant and pro-oxidant markers in preeclampsia.

Authors:  Mohd Suhail; Mohd Faizul Suhail; Hina Khan
Journal:  J Clin Biochem Nutr       Date:  2008-10-31       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.